CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  
jump over right navigation bar
Section II. Presentations and Panel Discussion
Welcome Address: Opening Remarks
Welcome Address: Behavioral and Social Science Research in Tuberculosis Control
Keynote Session: When Sacred Cows Become the Tigerís Breakfast: Defining A Role for the Social Sciences in Tuberculosis Control
Keynote Session: Behavior, Society and Tuberculosis Control
Preliminary Results from the Tuberculosis Behavioral and Social Science Literature Review
Neighborhood Health Messengers: Using Local Knowledge, Trust, and Relationships to Create Culturally Effective Tuberculosis Education and Care for Immigrant and Refugee Families
Psychosocial, Social Structural, and Environmental Determinants of Tuberculosis Control
Community Perspectives in Tuberculosis Control and Elimination: The Personal Experiences of Patients and Providers Panel Discussion
Group Discussion of Themes and Issues from Day One
Breakout Group Sessions I: Identifying Research Gaps and Needs
Turning Research into Practice Panel Discussion
Sharpening the Focus on Turning Research into Practice: The Promise of Participatory Research Approaches
Two CDC Models from HIV Prevention: Replicating Effective Programs and Diffusion of Effective Behavioral Interventions
Effective Intervention for Asthma
Potential Funding Opportunities
Closing Remarks: Maintaining the Momentum on Development of a Tuberculosis Research Agenda
 
Return to Table of Contents

The Tuberculosis Behavioral and Social Science Research Forum Proceedings

Section II. Presentations and Panel Discussions

DAY ONE

Mark Nichter, Ph.D., M.P.H.
Professor, Department of Anthropology, University of Arizona

Day 1, Afternoon Session

Dr. Nichter led Forum participants in a group discussion of themes that emerged during the first day of the Forum. The following is a summary of the main themes and issues discussed.

Patients’ needs

The group recognized the importance both of addressing the needs of TB patients, as well as overcoming the barriers to meeting those needs. More research is needed to gather patients’ perspectives on the following topics:

  • The value patients place on their health;
  • The continuum of patient needs, including social needs and access to medications;
  • Patients’ negative opinions about TB treatment;
  • Patients’ mistrust of government agencies as a barrier to TB treatment; and
  • The tradeoff between long-term benefits of taking TB medications and possible short-term drawbacks, such as unpleasant side effects.

Some underlying patient needs such as family support, housing, and financial assistance are well documented, but policy makers and funders must be convinced that addressing these needs may be critical to patient adherence to TB regimens. Families of TB patients can play either positive or negative roles in TB treatment. Supportive families may be especially important for adolescents and some ethnic groups.

Standardized and tailored approaches to working with TB patients must be balanced. Adherence to standardized TB treatment protocols is extremely important, but tailored interventions that meet patients’ individual needs may be required to facilitate such adherence.

Providers’ needs

More research should focus on identifying and understanding the needs of TB providers in areas such as adherence to guidelines and reimbursement for insured services. Providers also need more education and training on dealing with patients’ emotional issues.

Patient-provider relationship

Building trust between patients and providers requires early and ongoing attention. If treated with respect and sensitivity, clients who may initially be considered challenging often develop good relationships with clinicians. If a provider has undue suspicions of a patient or has assumptions about patient non-adherence, these may present additional barriers to working with TB patients.

Directly observed therapy programs

Participants discussed the strengths and limitations of DOT programs. Suggestions for improving these models included the following:

  • Comparison of home-based and clinic-based DOT models based on patients’ needs;
  • DOT programs designed to address issues of TB-related stigma in work and home environments;
  • Cost-effectiveness research comparing home- and clinic-based DOT models;
  • Research to identify the characteristics of subpopulations and patients for whom DOT is particularly effective; and
  • Research on the sustainability and educational and cultural appropriateness of different DOT approaches with diverse populations.

Health care systems

Standard TB treatment protocols are needed in health care settings. Additionally, TB control programs need capacity building to prepare for new developments and trends, such as the increasing diversity of populations affected by TB and the programs needed to reach varying patient groups.
Additional challenges for health systems involve the image and reputation of health departments and many patients’ mistrust of systems and the medications they provide. In particular, there is a need for better understanding of gender differences in seeking health services. Other health care systems issues that were discussed include the interactions between public health and private providers, and also those between different health care programs and services, e.g., the interaction between TB programs and HIV programs.

Policy makers

Policy makers have extremely important roles to play in the development and support of TB programs. As they make decisions about programs, policy makers should be encouraged to address the following issues:

  • TB education needs among patients, providers, and communities at large;
  • Underlying socioeconomic and cultural factors contributing to TB and influencing responses to TB programs;
  • Health insurance needs and problems associated with various insurance plans;
  • Funding and other resources needed to support and sustain effective TB programs; and
  • Disparities in TB rates among different populations.

 

 

 

 

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333